FindTrial
Sign In

Pelvic Health Issues and Muscle Strength in Cancer Patients receiving Radiation Therapy

Perceived Pelvic Floor Distress and Pelvic Floor Muscle Endurance in Individuals with Cancer receiving Pelvic Radiation Therapy. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/109200
Enrollment
86
Registered
2026-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Hetvi Desai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals diagnosed with a pelvic cancer and undergoing pelvic radiotherapy for at least two weeks (minimum of 10 sessions).

Exclusion criteria

Exclusion criteria: Patients will be excluded if they have open wounds or active pelvic skin infections, musculoskeletal impairments limiting pelvic assessment, or hemodynamic instability. Individuals with Stage IV metastatic disease, an ECOG performance status greater than 3, or pre-existing urinary or faecal incontinence will also be excluded.

Design outcomes

Primary

MeasureTime frame
pelvic muscle floor muscle endurance ( pressure biofeedback unit) and pelvic floor distress(PFDI-20 for women, MLUTS for men, CRADI-8 for both men and women)Timepoint: assessed at single time point. (baseline)—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactMrs Nivedita S Prabhu

Manipal College of Health Professions, MAHE, Manipal.

nivedita.kamath@manipal.edu9901729546

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026